{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-01-26T16%3A00%3A55.647Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpCreated=2018-01-26T16%3A00%3A55.647Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-01-26T16%3A00%3A55.647Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&_metadata=all&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpCreated=2018-01-26T16%3A00%3A55.647Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-01-26T16%3A00%3A55.647Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpCreated=2018-01-26T16%3A00%3A55.647Z&legislature.prefLabel=House+of+Commons&tablingMemberConstituency=Twickenham&answer.answeringMemberConstituency=Thurrock&max-answer.questionFirstAnswered.=2019-07-15T13%3A33%3A41.877Z", "items" : [{"_about" : "http://data.parliament.uk/resources/831118", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/831118/answer", "answerText" : {"_value" : "

The Medicines and Healthcare products Regulatory Agency (MHRA) have received 124 spontaneous reports of suspected adverse drug reactions (ADRs) via the Yellow Card Scheme from prescribers and patients in association with liothyronine in the United Kingdom as of 28 January 2018. The MHRA have not received any spontaneous cases where the reporter has stated their liothyronine is unlicensed.<\/p>

<\/p>

Of the 124 reports, six relate to a brand of liothyronine that is not licensed in the UK. However, it is important to note that patients may have been prescribed a medication while in a foreign country; therefore, a report of a foreign brand cannot be assumed as unlicensed use. Furthermore, while reporters are requested to provide as much detail as possible, detail of the medicinal brand or license is not a compulsory reporting criteria. Therefore, this information is not always provided.<\/p>

<\/p>

Yellow Card data should not be used as an indicator of the frequency of suspected ADRs to medicines. The level of ADR reporting may fluctuate over time due to a variety of reasons such as a medicine being new, stimulated interest/publicity and variations in exposure to the medicine.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2018-01-31", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-31T14:09:34.423Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-01-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Liothyronine"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many reports have been made by prescribers or patients to the Medicines and Healthcare products Regulatory Agency on unlicensed liothyronine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/207", "label" : {"_value" : "Biography information for Sir Vince Cable"} } , "tablingMemberConstituency" : {"_value" : "Twickenham"} , "tablingMemberPrinted" : [{"_value" : "Sir Vince Cable"} ], "uin" : "125126"} , {"_about" : "http://data.parliament.uk/resources/776100", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/776100/answer", "answerText" : {"_value" : "

Average waiting times for patients experiencing psychosis referred for primary care are not centrally held. NHS England publishes interim data on the percentage of patients with first episode of psychosis starting treatment within two weeks of referral, in line with the Early Intervention in Psychosis standard. This data has been available since December 2015 and it can be found at:<\/p>

<\/p>

https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2016/04/EIP-Waiting-Times-Timeseries-August-2017.xlsx<\/a><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-10-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-10-26T13:44:47.283Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-10-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the average waiting time was in each month since April 2015 for patients referred for primary care having suffered psychosis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/207", "label" : {"_value" : "Biography information for Sir Vince Cable"} } , "tablingMemberConstituency" : {"_value" : "Twickenham"} , "tablingMemberPrinted" : [{"_value" : "Sir Vince Cable"} ], "uin" : "108997"} , {"_about" : "http://data.parliament.uk/resources/773342", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/773342/answer", "answerText" : {"_value" : "

The Department is working to ensure the best outcome for the health and social care system. All relevant policy areas covered by the Department are involved with this work and assessing the implications of the United Kingdom leaving the European Union.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-10-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-10-23T16:43:05.857Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-10-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Organs: Donors"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the potential effect on UK supplies of donated tissues and cells of the UK leaving the EU without formal agreement on the UK remaining party to Directive 2004/23/EC.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/207", "label" : {"_value" : "Biography information for Sir Vince Cable"} } , "tablingMemberConstituency" : {"_value" : "Twickenham"} , "tablingMemberPrinted" : [{"_value" : "Sir Vince Cable"} ], "uin" : "108475"} , {"_about" : "http://data.parliament.uk/resources/773343", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/773343/answer", "answerText" : {"_value" : "

The Department is working to ensure the best outcome for the health and social care system. All relevant policy areas covered by the Department are involved with this work and assessing the implications of the United Kingdom leaving the European Union.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-10-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-10-23T16:44:29.103Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-10-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Blood: Donors"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the potential effect on blood supplies in the UK of the UK leaving the EU without formal agreement on the UK remaining party to Directive 2002/98/EC.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/207", "label" : {"_value" : "Biography information for Sir Vince Cable"} } , "tablingMemberConstituency" : {"_value" : "Twickenham"} , "tablingMemberPrinted" : [{"_value" : "Sir Vince Cable"} ], "uin" : "108476"} , {"_about" : "http://data.parliament.uk/resources/759343", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/759343/answer", "answerText" : {"_value" : "

The Department has asked the National Institute for Health and Care Excellence (NICE) to update its clinical guideline on attention deficit hyperactivity disorder (ADHD). The draft guideline, which was published for consultation on 6 September, provides evidence based recommendations on the diagnosis and management of ADHD in children, young people and adults.<\/p>

<\/p>

The draft guideline recognises that this condition is less likely to be diagnosed in girls and women or that they may be given an incorrect diagnosis as they are more likely to present with symptoms other than hyperactivity. The guideline advises practitioners to be alert in such circumstances to the possibility of ADHD.<\/p>

<\/p>

We expect clinical commissioning groups to take account of clinical guidelines published by NICE when commissioning services for their local populations. Whilst clinical guidelines are not mandatory, adherence to them will support improvements in the quality of care and services.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"} } , "answeringMemberConstituency" : {"_value" : "Thurrock"} , "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"} , "dateOfAnswer" : {"_value" : "2017-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-09-19T09:53:22.393Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-09-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Attention Deficit Hyperactivity Disorder"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps the Government is taking to improve the (a) diagnosis, (b) early intervention and (c) treatment of attention deficit hyperactivity disorder and attention deficit disorder (i) in general and (ii) specifically for girls.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/207", "label" : {"_value" : "Biography information for Sir Vince Cable"} } , "tablingMemberConstituency" : {"_value" : "Twickenham"} , "tablingMemberPrinted" : [{"_value" : "Sir Vince Cable"} ], "uin" : "9775"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }